About Contact Us Careers
Sign In

Trastuzumab Biosimilar Market - Top Companies and Manufacturers

  • Report ID: 3011
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Companies Dominating the Trastuzumab Biosimilar Landscape

    • Amgen Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Aryogen Biopharma
    • Biocon Limited
    • Celltrion Inc.
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Accord Healthcare Ltd.
    • Gedeon Richter PLC
    • Genor Biopharma Company Ltd.
    • Mabion S.A.
    • Mylan N.V.
    • Roche Holding AG

     

Browse Key Market Insights with Data Illustration:

In the News


Author Credits:  Radhika Pawar


  • Report ID: 3011
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising prevalence of cancer and increasing geriatric population in the world are the key factors driving market growth.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

The side-effects which are associated with the use of trastumuzab biosimilar are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing population and investments for trastumuzab biosimilar research.

The major players dominating the trastumuzab biosimilar market are Amgen Inc., Biocon Limited, Celltrion Inc., Pfizer Inc., Merck & Co. Inc., Accord Healthcare Ltd. among others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample